Premotor Cortex: A New Target for Stroke Motor Rehabilitation

NCT02565199 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-08-16

No results posted yet for this study

Summary

The goal of the study is to determine the effect of repetitive transcranial magnetic stimulation (rTMS) over the premotor cortex on training-related improvements in motor performance and associated neural plasticity.

Conditions

Interventions

DEVICE

rTMS over Premotor Cortex (Contralateral Hemisphere)

* Location of rTMS: premotor cortex * Frequency of rTMS: 0.1 Hz * Time of rTMS: 50 milliseconds before the onset of movement-related EMG * Device: MagStim Super Rapid 2 Transcranial Magnetic Stimulator

DEVICE

rTMS over Premotor Cortex (Ipsilateral Hemisphere)

* Location of rTMS: premotor cortex * Frequency of rTMS: 0.1 Hz * Time of rTMS: 50 milliseconds before the onset of movement-related EMG * Device: Super Rapid 2 Transcranial Magnetic Stimulator

DEVICE

rTMS (Control 1)

* Location of rTMS: premotor cortex * Frequency of rTMS: 0.1 Hz * Time of rTMS: 400 milliseconds after the onset of movement-related EMG * Device: Super Rapid 2 Transcranial Magnetic Stimulator

DEVICE

rTMS (Control 2)

* Location of rTMS: somatosensory cortex * Frequency of rTMS: 0.1 Hz * Time of rTMS: 50 milliseconds before the onset of movement-related EMG * Device: Super Rapid 2 Transcranial Magnetic Stimulator

DEVICE

rTMS (Control 3)

* Location of rTMS: premotor cortex * Frequency of rTMS: 0.1 Hz * Time of rTMS: 50 milliseconds before the onset of movement-related EMG * Device: Super Rapid 2 Transcranial Magnetic Stimulator with Sham Coil

OTHER

Motor Training

During motor training, participants will quickly extend their hand at a pace of one extension every 5 seconds (0.2Hz) in response to an auditory cue.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02565199 on ClinicalTrials.gov